So I was reading an interesting article from MSN how a company can now map your genome for a relatively small fee. It mentions something confusing, that being that
[...] the FDA restricts direct sales of health reports to consumers that have the potential to diagnose or change a course of treatment — information considered actionable [...]
Why would the FDA limit actionable material that may enhance treatment? I'm certain it's probably inbetween the lines of the linked article, but I don't understand why such information would not be made available to consumers.